Letters to the Editor
Early tocilizumab treatment could improve survival among COVID-19 patients
L. Campins1, R. Boixeda2, L. Perez-Cordon3, R. Aranega4, C. Lopera5, L. Force6
- Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain. lcampins@csdm.cat
- Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona; Grup d’Estudi al Maresme de la Pneumònia Adquirida en la Comunitat i la MPOC (GEMP@C), Mataró, Barcelona; and Universidad de Barcelona, CIBERES Barcelona, Spain.
- Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain.
- Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
- Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
- Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, and ESCS-TCMM, Pompeu Fabra University, Mataró, Barcelona, Spain.
CER13578
2020 Vol.38, N°3
PI 0578
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 32456769 [PubMed]
Received: 17/05/2020
Accepted : 20/05/2020
In Press: 27/05/2020
Published: 27/05/2020